These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1289 related articles for article (PubMed ID: 26168157)

  • 1. Correction: Correction: CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort.
    PLOS ONE Staff
    PLoS One; 2015; 10(7):e0133093. PubMed ID: 26168157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort.
    Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
    PLoS One; 2015; 10(6):e0130509. PubMed ID: 26061975
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa.
    Murphy RA; Marconi VC; Gandhi RT; Kuritzkes DR; Sunpath H
    PLoS One; 2013; 8(12):. PubMed ID: 29220839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.
    Nachega JB; Stein DM; Lehman DA; Hlatshwayo D; Mothopeng R; Chaisson RE; Karstaedt AS
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1053-6. PubMed ID: 15585095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
    Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C;
    PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained favourable HIV viral load response in South African patients during concomitant HAART and cancer therapy.
    Musyoki AM; Msibi TL; Motswaledi MH; Selabe SG; Mphahlele MJ
    J Med Virol; 2015 Feb; 87(2):192-8. PubMed ID: 25156795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models.
    Sempa JB; Rossouw TM; Lesaffre E; Nieuwoudt M
    PLoS One; 2020; 15(1):e0228218. PubMed ID: 31945145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
    Inzaule SC; Hamers RL; Kityo C; Rinke de Wit TF; Roura M
    PLoS One; 2017; 12(2):e0172077. PubMed ID: 28178336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of HIV in surgical patients in Soweto, South Africa: impact on resource utilisation and recommendations for HIV testing.
    Martinson NA; Omar T; Gray GE; Vermaak JS; Badicel M; Degiannis E; Steyn J; McIntyre JA; Smith M
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):176-82. PubMed ID: 16814822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa.
    Kakinami L; de Bruyn G; Pronyk P; Mohapi L; Tshabangu N; Moshabela M; McIntyre J; Martinson NA
    AIDS Behav; 2011 May; 15(4):823-31. PubMed ID: 20703794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda.
    Kaida A; Matthews LT; Kanters S; Kabakyenga J; Muzoora C; Mocello AR; Martin JN; Hunt P; Haberer J; Hogg RS; Bangsberg DR
    PLoS One; 2013; 8(6):. PubMed ID: 29161730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Towards Developing an Initial Programme Theory: Programme Designers and Managers Assumptions on the Antiretroviral Treatment Adherence Club Programme in Primary Health Care Facilities in the Metropolitan Area of Western Cape Province, South Africa.
    PLOS ONE Staff
    PLoS One; 2016; 11(11):e0166507. PubMed ID: 27829028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
    Conan N; Simons E; Chihana ML; Ohler L; FordKamara E; Mbatha M; vanCutsem G; Huerga H
    PLoS One; 2024; 19(2):e0299408. PubMed ID: 38377141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort.
    Phatlhane DV; Ipp H; Erasmus RT; Zemlin AE
    Clin Chem Lab Med; 2016 Mar; 54(3):501-8. PubMed ID: 26485747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.